⌕
iShares Biotechnology ETF · IBB · Nasdaq
A sector position · not Tenet-scored
Compare
$207.98−2.13%At close
$207.98−4.52 (−2.13%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

iShares Biotechnology ETF (IBB) Expense Ratio

Sources Fund holdings disclosures Fund disclosuresHow we compute thisNot investment advice

A 0.44% expense ratio sounds abstract. Here's what it is versus its Healthcare peers, and what any fee actually costs you in real dollars over time.

Expense ratio vs category

0.44%$44 per $10,000/yr
IBB0.44%
Category avg0.76%

Below category average. This fund costs about 0.58× the typical Healthcare peer's fee. Cheap for its category, though a plain broad-index fund can still cost less.

Peer set: US-listed Healthcare equity ETFs · fee point-in-time.

Fee-drag calculator · in dollars

Amount invested
Holding period
IBB fee cost (0.44%)$7,653
If it charged category avg (0.76%)$12,921
You keep$5,268

Fee dollars over 20 years on $25,000, assuming 7%/yr growth. Dollarising the fee is what actually changes behaviour.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.